Shridhar Narayanan

2.1k total citations
52 papers, 1.1k citations indexed

About

Shridhar Narayanan is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Shridhar Narayanan has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Infectious Diseases and 11 papers in Pharmacology. Recurrent topics in Shridhar Narayanan's work include Histone Deacetylase Inhibitors Research (9 papers), Tuberculosis Research and Epidemiology (9 papers) and Mycobacterium research and diagnosis (6 papers). Shridhar Narayanan is often cited by papers focused on Histone Deacetylase Inhibitors Research (9 papers), Tuberculosis Research and Epidemiology (9 papers) and Mycobacterium research and diagnosis (6 papers). Shridhar Narayanan collaborates with scholars based in India, United States and Saudi Arabia. Shridhar Narayanan's co-authors include Swaminathan Sethuraman, Uma Maheswari Krishnan, Balasubramanian Gopalan, Uma Maheswari Krishnan, Laxmikant A. Gharat, Radha Krishan Shandil, Srinivas Gullapalli, Sumesh Eswaran, Stalin Selvaraj and Ana Charrua and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain Research.

In The Last Decade

Shridhar Narayanan

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shridhar Narayanan India 17 542 203 133 116 116 52 1.1k
Ranjeet Prasad Dash United States 21 441 0.8× 121 0.6× 69 0.5× 146 1.3× 72 0.6× 52 1.2k
Gurdarshan Singh India 22 549 1.0× 146 0.7× 89 0.7× 181 1.6× 150 1.3× 73 1.4k
Lu Yang China 20 536 1.0× 206 1.0× 85 0.6× 77 0.7× 79 0.7× 58 1.5k
Mingna Sun China 18 280 0.5× 145 0.7× 80 0.6× 58 0.5× 83 0.7× 32 811
Benita Wiatrak Poland 19 389 0.7× 322 1.6× 59 0.4× 76 0.7× 45 0.4× 97 1.2k
Soo Jin Oh South Korea 21 619 1.1× 97 0.5× 201 1.5× 159 1.4× 170 1.5× 76 1.7k
Shiyu Liu China 20 439 0.8× 74 0.4× 58 0.4× 189 1.6× 118 1.0× 62 1.4k
Xuehua Zheng China 18 329 0.6× 112 0.6× 103 0.8× 59 0.5× 116 1.0× 51 864
Wen Liu China 19 584 1.1× 406 2.0× 56 0.4× 119 1.0× 93 0.8× 56 1.4k
Xavier Thuru France 17 682 1.3× 111 0.5× 161 1.2× 260 2.2× 104 0.9× 38 1.5k

Countries citing papers authored by Shridhar Narayanan

Since Specialization
Citations

This map shows the geographic impact of Shridhar Narayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shridhar Narayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shridhar Narayanan more than expected).

Fields of papers citing papers by Shridhar Narayanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shridhar Narayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shridhar Narayanan. The network helps show where Shridhar Narayanan may publish in the future.

Co-authorship network of co-authors of Shridhar Narayanan

This figure shows the co-authorship network connecting the top 25 collaborators of Shridhar Narayanan. A scholar is included among the top collaborators of Shridhar Narayanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shridhar Narayanan. Shridhar Narayanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravishankar, Vigneshwaran, Shridhar Narayanan, & Radha Krishan Shandil. (2024). Rickettsial infections: prevalence and diagnosis of scrub typhus in India. SHILAP Revista de lepidopterología. 5.
2.
Kaur, Parvinder, et al.. (2024). Apramycin kills replicating and non-replicating Mycobacterium tuberculosis. SHILAP Revista de lepidopterología. 5. 1 indexed citations
3.
Narayanan, Shridhar, et al.. (2023). Review of Analytical and Sample Processing Technologies for Detecting Antibiotic Residues in Environmental Samples. Indian Journal of Pharmaceutical Sciences. 85(6). 1 indexed citations
4.
Chu, Justin Jang Hann, et al.. (2023). Expanding the anti-flaviviral arsenal: Discovery of a baicalein-derived Compound with potent activity against DENV and ZIKV.. Antiviral Research. 220. 105739–105739. 6 indexed citations
5.
Kaur, Parvinder, et al.. (2023). A Novel Inhibitor against the Biofilms of Non-Tuberculous Mycobacteria. Pathogens. 13(1). 40–40. 5 indexed citations
6.
Narayan, Rohan, Sumandeep Kaur, Priya Rani, et al.. (2023). Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo. Cell Reports Medicine. 4(8). 101127–101127. 7 indexed citations
7.
Narayanan, Shridhar, et al.. (2021). Development and validation of LC/MS/MS method for Triciribine and its monophosphate metabolite in plasma and RBC: Application to mice pharmacokinetic studies. Journal of Chromatography B. 1174. 122714–122714. 1 indexed citations
8.
Subramani, Pradeep Annamalai, Bhavana Nayer, Noriko Yoshida, et al.. (2020). Plasmodium vivax liver stage assay platforms using Indian clinical isolates. Malaria Journal. 19(1). 214–214. 7 indexed citations
9.
Eswaran, Sumesh, et al.. (2018). Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety. Bioorganic & Medicinal Chemistry Letters. 29(1). 97–102. 57 indexed citations
10.
Paul‐Satyaseela, Maneesh, et al.. (2017). Novel hydroxamates potentiated in vitro activity of fluconazole against Candida albicans. Journal of Natural Science Biology and Medicine. 8(1). 119–119. 2 indexed citations
11.
12.
Kulkarni, Nagaraj M., Sandeep Malampati, S. Chandrasekaran, et al.. (2016). Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease. Drug Metabolism and Personalized Therapy. 31(3). 165–171. 10 indexed citations
13.
Rajagopal, Sridharan, D. Prabhu, Praveen Rajendran, et al.. (2015). Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts. European Journal of Medicinal Chemistry. 108. 274–286. 7 indexed citations
14.
Narayanan, Shridhar, et al.. (2015). Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma. European Journal of Pharmaceutics and Biopharmaceutics. 99. 73–83. 55 indexed citations
15.
16.
Chandrasekhar, K. B., et al.. (2015). Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo. European Journal of Pharmacology. 764. 508–519. 15 indexed citations
17.
Kulkarni, Nagaraj M., et al.. (2014). A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation. Pharmaceutical Biology. 53(8). 1110–1117. 16 indexed citations
18.
Kulkarni, Nagaraj M., et al.. (2014). Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation. Archives of Pharmacal Research. 38(6). 1238–1247. 21 indexed citations
19.
20.
Narayanan, Shridhar, et al.. (2004). Analgesic studies on total alkaloids and alcohol extracts of Eclipta alba (Linn.) Hassk.. Phytotherapy Research. 18(2). 111–113. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ranjeet Prasad Dash Breakdown of academic impact, for papers by Gurdarshan Singh Breakdown of academic impact, for papers by Lu Yang Breakdown of academic impact, for papers by Mingna Sun Breakdown of academic impact, for papers by Benita Wiatrak Breakdown of academic impact, for papers by Soo Jin Oh Breakdown of academic impact, for papers by Shiyu Liu Breakdown of academic impact, for papers by Xuehua Zheng Breakdown of academic impact, for papers by Wen Liu Breakdown of academic impact, for papers by Xavier Thuru
Rankless by CCL
2026